• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Dr Paul P. Doghramji: Prescribing Biosimilars in IBD

Video

Paul P. Doghramji, MD, FAAFP, discusses whether he has begun to prescribe biosimilars for patients with inflammatory bowel disease.

Transcript:

Are you or any of your colleagues beginning to prescribe biosimilars?

I haven’t started prescribing biosimilars yet for these diseases. I tend to use brand names more than anything, but sometimes I’m forced to do it because of insurance constraints. As a general rule, we like to use a medication that’s come out by that specific pharma company in that brand name because we know exactly what we’re getting.

Recent Videos
Canavan & O’Dell
Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health.
Elena Wolff-Holz, MD.
Elena Wolff-Holz, MD, global head of clinical development at Biocon Biologics
Elena Wolff-Holz, MD
Travis Brewer, Texas Oncology
Josh Canavan, PharmD, head of pharmacy at RazorMetrics
Tiago Biachi, MD, PhD
Elie Bahou, MD, PhD
Steve Pickette, PharmD
Related Content
© 2025 MJH Life Sciences

All rights reserved.